Vallon Pharmaceuticals, Inc. announced that on May 16, 2022, the Board appointed Marella Thorell as chairperson of the Board. In addition, on May 16, 2022, Ms. Thorell resigned as chairperson of the Audit Committee and the Board appointed Meenu Karson as the new chairperson of the Audit Committee.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4158 USD | +2.54% | +1.63% | -93.94% |
16/04 | GRI Bio Receives South Korea Patent for Liver Inflammatory Condition Treatments | MT |
2023 | Vallon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
- Stock Market
- Equities
- GRI Stock
- News GRI BIOPAR
- Vallon Pharmaceuticals, Inc. Announces Board Changes